ACET Adicet Bio: Accounting Value per Share

Graphic logo of Adicet Bio, Inc. (ACET)

High bioreactor utilization and the pristine condition of Adicet Bio facilities support asset dynamics; consequently, the GURU.Markets platform displays a book value per share analysis, where 12.93 serves as the current value of the metric. The fundamentals are based on the creation of ready-made GVHD-free T-cell products, while future revenues rely on settlements with insurance funds and oncology centers for the treatment of lymphomas.

Adicet (ACET): Share Book Value from 07/04/2022 to 10/26/2026

Adicet Bio Inc. - analytical breakdowns and key metrics (ACET)

- price and consensus price forecast:
Stock Price Adicet|ACET - Average Forecast Price
- market capitalization data:
Market Valuation Adicet Bio, Inc.|ACET - Aggregate Business Value
- book capitalization data:
Net Assets per Single Share Adicet Bio|ACET - Net Asset Value|Market Capitalization to Book Value Ratio adicetbio.com|ACET - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Adicet Bio|ACET - Long-Term Debt to Capital|Short-Term Debt to Equity Adicet|ACET - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Adicet Bio, Inc.
Fundamental company valuation:adicetbio.com - ACET
Manufactured products of Adicet

Capital transparency is critical when selecting defensive assets, which for Adicet Bio (ACET) is confirmed by the attraction of investments from global pharma behemoths to develop gamma-delta T-cell therapy. The published book value per share reflects the difference between all assets and liabilities, allowing investors to assess the real value of net assets and identify hidden write-downs that distort the quality of the company's balance sheet.

Competitors of Adicet Bio (ACET)

ARGX (Argenx) - Book Value per Share|BioNTech Pharma (BNTX) - Net Asset Value per Share|ABVX - Accounting Value per Share|ADMA (admabiologics.com) - Book Price of a Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|Net Asset Value per Share AnaptysBio Inc ANAB|Astria Pharma - Book Value per Share|ENGN - Book Value per Share|Book Value per Share RAPT Therapeutics, Inc.|Aerovate Therapeutics (JBIO) - Equity per Share|ACRS: Book Value per Share|Net Assets per Share Kyverna Therapeutics Inc.|Book Value per Share TLSA (Tiziana Life Sciences PLC)|Accounting Value per Share Cabaletta Bio Inc (CABA)|VTYX: Book Value per Share|THTX - Net Asset Value per Share|Accounting Value per Share Avalo Therapeutics AVTX|Eledon Pharmaceuticals Inc. (ELDN) - Book Price of a Share|Accounting Value per Share Agenus Inc AGEN|Climb Bio, Inc (CLYM) - Accounting Value of a Share|Book Value per Share Zura Bio Limited|Net Assets per Single Share atyrpharma.com|ADAG (Adagene) - Book Value per Share|Net Assets per Share IMA (ikenaoncology.com)|STTK: Net Assets per Single Share|Net Asset Value per Share Equillium Inc EQ|Connect Pharma - Book Value per Share|IMUX - Book Value per Share|ATRA (atarabio.com) - Book Value per Share|InflaRx (IFRX) - Accounting Value per Share|Book Value per Share XFOR (X4 Pharma)|Net Asset Value per Share Celularity Corp (CELU)|Accounting Value per Share INmune Bio, Inc.|Book Price of a Share BRNS (barinthusbio.com)|Kezar Life Sciences, Inc. (KZR) - Net Assets per Single Share|Share Book Value SAB Biotherapeutics Inc. SABS|Book Value per Share Akari Therapeutics plc (AKTX)|ENLV - Accounting Value of a Share|QTTB: Book Value per Share|GOVX (geovax.com) - Book Value per Share|EDSA - Net Assets per Single Share|Accounting Value of a Share IBIO|Net Assets per Single Share CARM (Carisma Therapeutics)|Accounting Value per Share XTL Bio (XTLB)|Book Value per Share BOLT (Bolt Biotherapeutics, Inc.)|HCWB - Book Value per Share|Accounting Value per Share Aptevo (APVO)|AIM - Accounting Value of a Share|aditxt.com - Book Value per Share|GRI (GRI Bio Corporation) - Net Assets per Share|Net Assets per Single Share XRTX|Accounting Value per Share HIND|Net Assets per Single Share REVB (Revelation Biosciences, Inc.)|Accounting Value per Share Indaptus Therapeutics Inc INDP|Accounting Value per Share SCNI (Scinai)|CalciMedica Inc - Book Value per Share|Affimed Therapeutics (AFMD) - Net Assets per Single Share|ALLK - Equity per Share|Book Value per Share HOOK|IGM Biosciences (IGMS) - Net Asset Value per Share|ITOS (iTeos) - Book Value per Share|Book Value per Share Ocean Biomedical Corp|Book Value per Share TC Biopharm TCBP|Equity per Share thirdharmonicbio.com (THRD)